Several g-herpesviruses encode proteins related to the mammalian cyclins, regulatory subunits of cyclindependent kinases (cdks) essential for cell cycle progression. We report a 2.5 A Ê crystal structure of a full-length oncogenic viral cyclin from g-herpesvirus 68 complexed with cdk2. The viral cyclin binds cdk2 with an orientation different from cyclin A and makes several novel interactions at the interface, yet it activates cdk2 by triggering conformational changes similar to cyclin A. Sequences within the viral cyclin N-terminus lock part of the cdk2 T-loop within the core of the complex. These sequences and others are conserved amongst the viral and cellular D-type cyclins, suggesting that this structure has wider implications for other cyclin±cdk complexes. The observed resistance of this viral cyclin±cdk complex to inhibition by the p27 Kip cdk inhibitor is explained by sequence and conformational variation in the cyclin rendering the p27 Kip -binding site on the cyclin subunit non-functional.
Introduction
Progression through the mammalian cell cycle is controlled by distinct cyclin-dependent protein kinases whose catalytic activities are regulated by a variety of mechanisms (Morgan, 1995; Pines, 1999) . These serine/threonine kinases consist of two subunits: a cyclin protein and a cyclin-dependent kinase (cdk) (Morgan, 1997) . Members of the cyclin family bind to and activate speci®c cdk isozymes and their relative abundance varies during the cell cycle, leading to the periodic activation and inactivation of different cdks (Morgan, 1997) . Cdk phosphorylation and levels of cdk inhibitors (CKIs) also affect cdk catalytic activity (Pines, 1999) . One well studied cell cycle transition in mammalian cells is the mitogen-dependent entry into S-phase (DNA synthesis), which requires the coordinated activation of cyclin D±cdk4, cyclin D±cdk6 and cyclin E±cdk2 complexes (Sherr, 1994 (Sherr, , 1995 . Deregulation of the cyclin D-dependent kinases and their downstream targets has frequently been associated with many forms of cancer, underlining the importance of this pathway (Palmero and Peters, 1996; Sherr, 1996) . In addition to their catalytic role as protein kinases, speci®c cyclin±cdk complexes have also been proposed to have non-catalytic roles. The cyclin D±cdk4 and cyclin D±cdk6 holoenzymes phosphorylate the retinoblastoma protein pRb but also sequester the cdk inhibitors p21 Cip/WAF and p27 Kip , which otherwise block cyclin A±cdk2 and cyclin E±cdk2 kinase activity necessary for S-phase entry (reviewed in Sherr and Roberts, 1999) .
Cyclin homologues have been identi®ed within the genomes of several g-herpesviridae associated with neoplastic disorders, these include herpesvirus saimiri (HSV) (Albrecht et al., 1992; Jung et al., 1994) , Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) (Chang et al., 1996; Russo et al., 1996a) and murine g-herpesvirus 68 (Virgin et al., 1997) . Herein these viral cyclins will be referred to as V-, K-and M-cyclins, respectively. The viral cyclins are most closely related to the mammalian D-type cyclins, and K-and V-cyclin have been shown to form active complexes with cdk6 (Jung et al., 1994; Chang et al., 1996; Godden-Kent et al., 1997; Li et al., 1997) . Cdk6 bound by K-cyclin exhibits potent activity towards an extended range of substrates including histone H1 and p27 Kip (Godden-Kent et al., 1997; Ellis et al., 1999; Mann et al., 1999) . In addition, the K-cyclin±cdk6 and V-cyclin± cdk6 complexes are resistant to the p16 Inka and p21 Cip/WAF / p27 Kip CKIs and thereby overcome constraints to cell cycle progression mediated by their inhibitors (Swanton et al., 1997) . The ability of these viral cyclins to deregulate the cell cycle may provide a cellular environment conducive to viral replication, although their precise role in oncogenicity is not clear (reviewed in Laman et al., 2000) .
Structural analyses of a fragment of cyclin A bound to cdk2 have revealed the molecular basis for the partial and full catalytic activation of cdk2 (Jeffrey et al., 1995; Russo et al., 1996b) . Cyclin A associates with its catalytic partner cdk2 through a conserved region of~150 amino acids known as the cyclin box (Brown et al., 1995; Jeffrey et al., 1995) . In the presence of cyclin A, two regions of particular importance, the PSTAIRE helix and the T-loop bearing the activating phosphorylation site at Thr160, undergo a dramatic conformational change to in¯uence ATP coordination and the proper formation of a substratebinding cleft (Jeffrey et al., 1995; Russo et al., 1996b) . Further studies on a ternary complex of a p27 Kip peptide bound to cdk2 and a cyclin A fragment de®ned two independent p27 Kip -binding sites, one within cyclin A and a second within the cdk2 ATP-binding pocket (Russo et al., 1996c) . p27 Kip directly inhibits cyclin A±cdk2 by mimicking the adenosine moiety of ATP and making similar Crystal structure of a g-herpesvirus cyclin±cdk complex The EMBO Journal Vol. 19 No. 12 pp. 2877±2888, 2000 ã European Molecular Biology Organization contacts to cdk residues within the ATP-binding site (Russo et al., 1996c) . The structures of two further cyclins, cyclin H and V-cyclin, have been determined in their unbound form, demonstrating that all three cyclins have similar three-dimensional folds despite their limited sequence similarity (Brown et al., 1995; Kim et al., 1996; Andersen et al., 1997; Schulze-Gahmen et al., 1999) . As part of a study to understand the biochemical and structural properties of viral cyclins, we have determined the structure of the cyclin from g-herpesvirus 68 bound to cdk2. We describe novel features of the viral cyclin±cdk2 interaction when compared with the structure of cyclin A±cdk2 and discuss the functional implications for cdk recognition and regulation.
Results
We have focused on the cyclin from g-herpesvirus 68 as a model cyclin to understand the interaction between virusderived cyclins and the mammalian cdk enzymes. We ®rst determined which cdk subunit was bound by M-cyclin. As shown by co-immunoprecipitation experiments using FLAG-tagged M-cyclin, we demonstrated that M-cyclin binds to cdk2 in vivo rather than the canonical D-type cdkbinding partners cdk4 and cdk6 ( Figure 1A ). However, the closely related viral cyclin, K-cyclin, has been shown to associate with and activate cdk2, cdk4 and cdk6 ( Figure  1A ) (Godden-Kent et al., 1997; Li et al., 1997; Mann et al., 1999) .
One of the striking features of V-cyclin±cdk6 and K-cyclin±cdk6 complexes is their ability to evade inhibition by p21 Cip/WAF and p27 Kip . This is due to the lack of stable interaction between these cyclin±cdk complexes and CKIs. We assessed the degree of resistance of M-cyclin±cdk2 complexes to inhibition by p27 Kip . As shown in Figure 1B , M-cyclin±cdk2 was at least an order of magnitude less sensitive to inhibition by p27 Kip than cyclin A±cdk2. We also characterized an H175 to R175 mutant of M-cyclin (denoted as H175R in Figure 1 and elsewhere in the text as M-cyclin) and showed that it has identical functional properties to wild-type M-cyclin ( Figure 1B ). Since this mutant had an improved solubility pro®le (G.L.Card, N.Jones and N.Q.McDonald, unpublished data) , we concentrated our structural analysis on the H175R M-cyclin bound to cdk2.
M-cyclin±cdk2 complexes were prepared using an Escherichia coli host to produce M-cyclin and a recombinant baculovirus to produce cdk2 in Sf9 insect cells. The two puri®ed proteins were mixed in solution and gel ®ltered prior to concentration and crystallization. In vitro kinase assays using histone H1 as substrate indicated that the M-cyclin±cdk2 complex was partially active in the absence of cdk2 phosphorylation at T160 k2 (Thr160 of cdk2, the superscript letter identi®es the protein to which the residue belongs, i.e. A for cyclin A, M for M-cyclin, p27 for p27 Kip and k2 for cdk2) (data not shown). The same is also true for cyclin A±cdk2 (Russo et al., 1996b) . We observed an~50-fold increase in kinase activity using T160 k2 -phosphorylated cdk2 and M-cyclin (data not shown). Crystallization screens identi®ed conditions that gave monoclinic crystals belonging to space group P2 1 with cell dimensions 87.6 3 73.5 3 107.7 A Ê , b = 102.2°and two M-cyclin±cdk2 complexes per asymmetric unit. These crystals grew as thin plates with dimensions rarely greater than 5 mm and required intense synchrotron radiation to collect high resolution data from a single crystal. The M-cyclin±cdk2 structure was determined by molecular replacement and re®ned at 2.5 A Ê to an R-factor of 23.5% (R free of 28.5%) with excellent geometry (Table I ). There were no appreciable differences between the structures of either complex, and the rootmean-square deviation (r.m.s.d.) was 0.719 A Ê for 529 C a atoms. One of the two complexes (complex A) within the asymmetric unit had better de®ned electron density and correspondingly lower temperature factors, and only this The left panel shows wild-type and H175R M-cyclin complexes with cdk2 immunoprecipitated through the cyclin component and assayed against pRb. In vitro kinase assays were performed in the presence of increasing amounts of p27 Kip and show the reduced sensitivity of wild-type and mutant M-cyclin towards this inhibitor compared with cyclin A. The lower panel shows a bar graph of the decrease in kinase activity due to increased inhibitor concentrations. 32 P counts incorporated into pRb were quantitated on a phosphoimager and normalized to the amount of total kinase activity present when no inhibitor was used. complex is discussed. For complex A, residues 6±252 of M-cyclin are ordered, as are all of the residues in cdk2 with the exception of 10 and 11.
Overall structure of the M-cyclin±cdk2 complex The bi-lobal structure of cdk2 comprises an ATP-binding site and catalytic centre located between an N-terminal (N-lobe) and C-terminal lobe (C-lobe). M-cyclin binds cdk2 by interacting with hydrophobic sequences from the PSTAIRE region (residues 38±56) and strands b4/b5 of the N-lobe (Figure 2 ). It also makes important contacts with the T-loop in the C-lobe ( Figure 2C ). The cdk2-binding site on M-cyclin includes sequences within the cyclin box (residues 44±145) and the N-terminus ( Figure  2 ). There are several unique features to the M-cyclin±cdk2 structure; M-cyclin binds cdk2 with a relative disposition different from that of cyclin A such that structurally equivalent residues make different contacts with cdk2 with few interactions identical to the cyclin A±cdk2 interface ( Figure 2C ; Table II ). The¯exibility of the cdk2 N-lobe allows for an optimized packing with M-cyclin and ensures that M-cyclin is still able to partially activate cdk2 by promoting the realignment of the PSTAIRE helix similarly to cyclin A.
Basis for the resistance of M-cyclin±cdk2 to the p27 Kip cdk inhibitor Structural studies with a p27 Kip -derived peptide complexed to cyclin A±cdk2 have con®rmed that two distinct binding sites for p27 Kip exist within the cyclin A±cdk2 complex (Russo et al., 1996c) . One is located in the cyclin subunit and a second in the ATP-binding cleft of the cdk subunit. Additional contacts are made with the cdk2 N-lobe as p27 Kip bridges these two independent sites (Russo et al., 1996c) . To establish why viral cyclins such as M-and K-cyclin form active complexes that are resistant to the cdk inhibitor p27 Kip , we examined equivalent regions on cyclin A and M-cyclin that de®ne the p27 Kip -binding site. As we predicted previously, the acidic residues E220 A and D283 A , which form salt bridges with R30 p27 and K25 p27 , are replaced by uncharged side chains in M-cyclin, suggesting that electrostatic repulsion prevents p27 Kip interaction . In addition, the presence of basic or polar residues S93 M and K135 M in place of L255 A and L297 A replaces two critical buried interface residues within the p27±cyclin A complex and would also be expected to disrupt the interaction between p27 Kip and viral cyclins.
Unexpectedly, we found that two structural elements of M-cyclin also impede p27 Kip interaction. The main chain position of the H4±H5 loop leads to a steric clash with the p27 Kip peptide conformation observed bound to cyclin A ( Figure 3C ). Also, one of two helices found only in M-cyclin, helix HC (residues 247±250), lies close to the cyclin A-binding site for p27 Kip ( Figure 3C ). This positions residue F248 M within 2.1±2.2 A Ê of R30 p27 and L32 p27 side chains. It is also possible that the different disposition of the viral cyclin to cdk2 compared with cyclin A may further preclude interaction between p27 Kip and viral cyclin by disrupting a continuous complementary surface bridging across from the cyclin to cdk2 (Russo et al., 1996c) .
Structural comparison of a viral and non-viral cyclin bound to cdk2
Superposition of the cdk2 subunit from the cyclin A±cdk2 structure onto M-cyclin±cdk2 indicates no gross changes in cdk2 conformation (excepting the T-loop) with an r.m.s.d. of 1.209 A Ê for 234 C a atoms of cdk2 (from a total of 284). As mentioned previously, the superposition reveals that the M-cyclin is translated by~4 A Ê towards the cdk2 N-lobe, relative to cyclin A ( Figure 3A ). This brings the M-cyclin N-terminus into the cdk2 interface and ensures that sequences from M-cyclin make different contacts with cdk2 than equivalent residues in cyclin A ( Figure 4B ; Table II ). The M-cyclin±cdk2 interface has a smaller total buried surface area than that found for cyclin A±cdk2 (2269 A Ê 2 compared with 3002 A Ê 2 ). M-cyclin contributes 1146 A Ê 2 to the complex (cyclin A contributes 1679 A Ê 2 ), of which just under a third is due to the N-terminus. This is smaller than cyclin A as fewer side chains from helix HN1 participate in the M-cyclin±cdk2 interface ( Figure 3B ).
The major hydrophobic contacts in the M-cyclin±cdk2 interface centre on the PSTAIRE helix and strands b4 and b5 of the cdk2 N-lobe ( Figure 4A and B). A critical residue in this region is W142 M , which packs against H71 k2 , V69 k2 and L76 k2 within a hairpin turn between strands b4 and b5 at the tip of the cdk2 N-lobe ( Figure 4B ). This region has much lower atomic temperature factors than the equivalent region of cyclin A-bound cdk2. The C a atoms of the equivalent residues W142 M and F304 A are~3.5 A Ê apart but, in contrast to W142 M , the side chain of F304 A makes van der Waals contact with I52 k2 of the PSTAIRE helix ( Figure 4B ). M-cyclin residues I101 M , V105 M , L137 M and A144 M de®ne a shallow hydrophobic cavity, which packs against residue I49 k2 of the PSTAIRE helix ( Figure 4A and B). An equivalent cavity in cyclin A is located closer to the C-lobe of cdk2 ( Figure 4A ). Residues I49 k2 and L54 k2 R sym is de®ned as SI ± <I>|/SI, where I is the observed intensity and <I> is the average intensity from multiple measurements. R-factor is de®ned as SFp ± |Fc||/SFp, where |Fp| is the protein structure factor amplitude and |Fc| is the calculated structure factor amplitude. a Highest resolution shell in parentheses.
Crystal structure of a g-herpesvirus cyclin±cdk complex adopt different rotamers to cyclin A-bound cdk2, and the PSTAIRE helix is tilted at the N-terminal end optimizing packing interactions with M-cyclin ( Figure 4A ). In the M-cyclin±cdk2 structure, I49 k2 ®lls part of the space occupied by F304 A whilst L54 k2 tucks into the core of cdk2 towards the T-loop ( Figure 4B ). Also R50 k2 makes two hydrogen bonds to main chain carbonyl groups of K104 M and A107 M , reminiscent of the hydrogen bonds it makes to cyclin A in phosphorylated cdk2 (Russo et al., 1996b) . Residues 6±16 of the M-cyclin tuck under F152 k2 of the T-loop, tethering this region at the centre of the cyclin±cdk interface. Notably, D11 M hydrogen-bonds with S181 k2 and forms a salt bridge to R150 k2 as discussed later. L14 M occupies a small pocket below R122 k2 . These sequences form an important part of the cyclin±cdk interface and also contribute to a small hydrophobic core within M-cyclin, packing against several aromatic side chains from the cyclin box (F9 M and L15 M contact C154 M , Y155 M , H158 M and Y167 M ).
Of the few contacts to cdk2 conserved between both cyclin A and M-cyclin, the majority cluster either side of the PSTAIRE helix. The salt bridge formed by K104 M and E133 M (equivalent to K266 A and E295 A ) is of particular importance as it also makes three hydrogen bonds with cdk2, identical to cyclin A: one to the main chain carbonyl group of E42 k2 , and one to both the amide and carbonyl groups of V44 k2 (Table II) . This is surprising in view of the different position of the two cyclins, but can be explained by a compensating shift in residues 42±51 of cdk2, which include the N-terminal end of the PSTAIRE helix and its preceding loop ( Figure 4C ). The position of the PSTAIRE helix in the M-cyclin±cdk2 structure still permits E51 k2 to salt-bridge with the functionally important K33 k2 (2.7 A Ê Oe1 of E51 A to Nz K33 A ), analogous to the situation with cyclin A (Jeffrey et al., 1995) . L130 M and L137 M (equivalent to L292 A and L299 A )¯ank either side of the K104 M ±E133 M salt bridge, the latter being part of the cavity contacting the PSTAIRE helix described earlier.
Close to the C-terminal end of the PSTAIRE helix, V143 k2 packs against the aliphatic portion of K104 M , as well as side chains from R26 M and D145 M , which form an ion pair and also make van der Waal contacts to F152 k2 . Also, D19 M (equivalent to D181 A ) makes a favourable charge interaction with K278 k2 but is too distant to form the salt bridge seen for cyclin A±cdk2. Four ordered water molecules are also found at the cyclin±cdk interface, of which the most signi®cant solvent-mediated contact is that between the Oe1 atom of E133 M and carbonyl oxygen of V44 k2 , identical to that seen in cyclin A (Oe1 atom of E295 A ) ( Figure 4C ).
T-loop conformation in the M-cyclin±cdk2 complex
The conformation of the T-loop of cdk2 is highly sensitive to phosphorylation of T160 k2 by cdk-activating protein kinases and to the presence of a bound cyclin subunit (Jeffrey et al., 1995; Russo et al., 1996b) . Both M-cyclin± cdk2 complexes within the asymmetric unit have an identical T-loop conformation and this differs appreciably from previously reported structures. T-loop residues 148± 157 form two antiparallel b-strands as part of a threestranded b-sheet directly below the PSTAIRE helix (Figures 2 and 5B ). This b-sheet platform contributes several hydrophobic side chains, which pack against the PSTAIRE helix, notably A149 k2 , A151 k2 and V156 k2 . In contrast, other sequences in this region, including R150 k2 , F152 k2 and V154 k2 , are involved intimately in the M-cyclin±cdk2 interface ( Figures 4B and 5B) . In particular, R150 k2 forms a salt bridge with D11 M from the N-terminus of M-cyclin and adopts a quite different position to that found in cyclin A-activated cdk2 ( Figure  5A and B). R150 k2 is one of three arginine side chains that coordinate phospho-T160 k2 in cyclin A-bound cdk2 ( Figure 5B ) (Russo et al., 1996b) . The other two arginines in close proximity, R50 k2 and R126 k2 , have a very similar conformation to that seen in a cyclin A±phosphorylated cdk2 complex (Russo et al., 1996b) .
The conformation of T-loop residues 157±165, including T160 k2 , also deviates from that seen in previous structures. Comparison with a cyclin A±phosphorylated cdk2 bound to a substrate peptide indicates that the T-loop S46  k266  R50  k104  R50  f267  R50  a107  S53  d145  K56  D305  E57  Y185  H71  D138  H71  H296  R122  d11  R122  a307  R122  Y155  R122  E269  R150  D11  R150  e269  R150  i270  v156  N173  y180  N173  S181 D11  N272  e174  S276  D177  a277  Y178  K278  N16  K278  D181  k278  Y178 Hydrogen bonds were de®ned by CONTACT (CCP4, 1994) . Side chain±side chain hydrogen bonds are indicated by upper case and side chain±main chain by lower case, with conserved bonds indicated in bold. A distance criterion of 3.2 A Ê was used. The major hydrophobic contacts are shown in Figure 4B and are described in the text. Crystal structure of a g-herpesvirus cyclin±cdk complex lies directly along the path of a substrate peptide with several steric clashes and may contribute to the partial activity exhibited by the M-cyclin±cdk2 complex.
Similarly to the T-loop of cyclin A-bound unphosphorylated cdk2, V164 k2 does not adopt an a L conformation critical for substrate binding (Brown et al., 1999) .
M-cyclin±cdk2 as a model for other cyclin±cdk complexes In order to establish whether the M-cyclin±cdk2 complex would provide a good model for other viral and D-type cyclin±cdk complexes, we ®rst compared the structure of M-cyclin with those of V-cyclin and cyclin A (Brown et al., 1995; Jeffrey et al., 1995; Schulze-Gahmen et al., 1999) . The r.m.s.d. is 1.44 A Ê for 164 C a atoms between M-cyclin and cyclin A, and 1.79 A Ê for 173 C a atoms between M-cyclin and V-cyclin. Superposition of the three cyclins reveals several structural elements unique to M-cyclin. These include helices HN and HN2, the H4± H5 loop and helix HC ( Figure 3B ). Helices HN and HC were not observed in the V-cyclin structure due either tō exibility or to the intermediate resolution of the structure (Schulze-Gahmen et al., 1999), whereas sequences in V-cyclin and cyclin A equivalent to helix HN2 adopt a loop conformation. The H4±H5 loop is more extended in M-cyclin than in other cyclins and has the sequence G121 M , G122 M and A123 M , which overlaps the p27 Kipbinding site on cyclin A, as described earlier.
The majority of sequences conserved between the M-cyclin and V-cyclin are located within their buried cores, and these proteins clearly demonstrate a closer structural relationship with one another than with cyclin A ( Figure 3B ). This is consistent with the sequence similarity of viral cyclins and cellular cyclins in the cyclin box (the second helical cyclin domain is far more divergent in sequence than the cyclin box and is therefore an unreliable guide). The cyclin box of M-cyclin shares 36% identity to K-cyclin and 30% to V-cyclin and cyclin D3, compared with 23% identity to cyclin A. Several residues on the surface of M-cyclin and V-cyclin are also strictly conserved in all viral cyclin and D-type cyclin sequences ( Figure 3B ). These include D11 M , W142 M , D151 M and R106 M (conserved as a basic side chain; R106 M forms a salt bridge with D151 M ), all of which contribute to the M-cyclin±cdk2 interface. This`®ngerprint' is distinct from the nine residues that are conserved amongst the majority of mammalian cyclin sequences, six of which are buried within the cyclin hydrophobic core (R49 M , W55 M , L72 M , D78 M , Q92 M and L140 M ) whereas the other three contribute to the cdk interface (K104 M , P110 M and E133 M ). We therefore propose that the presence of the four conserved surface residues in viral and D-type cyclins is consistent with these cyclins engaging their cdk partners in a manner similar to M-cyclin.
Discussion
To understand the basis of viral cyclin interaction with mammalian cdk enzymes, we have focused our biochemical and structural efforts on M-cyclin, the viral cyclin from murine g-herpesvirus 68 (Virgin et al., 1997) . Although the in vivo oncogenic effects of M-cyclin expression have been established in transgenic mice (van Dyk et al., 1999) , its molecular properties remain uncharacterized. We ®rst examined M-cyclin's ability to associate with and activate different cdks and showed that its preferred cdk partner is cdk2, similar to cyclins A and E. M-cyclin differs from other viral cyclins in its restricted cdk preference. For example, K-cyclin is more promiscuous and can activate cdk2, cdk4 and cdk6 (Godden-Kent et al., 1997; Mann et al., 1999) . We also demonstrated that M-cyclin is able to reduce the sensitivity of cdk2 to inhibition by p27 Kip by at least 10-fold, analogous to the ability of K-cyclin to block inhibition of cdk6 by p27 Kip (Swanton et al., 1997) .
We then determined the crystal structure of a partially active M-cyclin±cdk2 complex at 2.5 A Ê resolution by molecular replacement. This structure provides the ®rst crystallographic evidence that signi®cant differences exist in the way two different cyclins can bind to and activate the same cdk subunit. This has important implications for other cyclin±cdk complexes. M-cyclin and cyclin A bind to cdk2 and activate it through repositioning the same cdk structural elements. Remarkably, however, the different relative disposition of cyclin and cdk in each complex ensures that very few interface contacts are conserved identically. The exception is the K104 M /E133 M sequence which contacts carbonyl and amide groups of E42 k2 and V44 k2 , a`hot spot' binding epitope at the cyclin±cdk interface. That such differences might exist was suggested from a model for V-cyclin±cdk6 derived from cyclin A± cdk2, which indicated several bad contacts close to the PSTAIRE helix and elsewhere (Schulze-Gahmen et al., 1999) .
The different cyclin disposition in M-cyclin±cdk2 is indicative of the plasticity of the cyclin±cdk interface. Despite a translation of 4 A Ê relative to cyclin A, M-cyclin packs against the cdk2 N-lobe using primarily hydrophobic interactions close to W142 M and the PSTAIRE helix. The conformational¯exibility of cdk2 within the N-lobe allows for optimization of interactions with M-cyclin close to W142 M by readjusting the position of the hairpin turn between strands b4 and b5. Although -cyclin (gold) and cyclin A (purple) following superposition through their respective cdk2 subunits. The helices of each cyclin are rendered as cylinders emphasizing the structural differences close to the M-cyclin N-and C-termini. These regions have important implications for interaction with the cdk2 T-loop and the basis for p27 Kip resistance as described in the text. Helices of M-cyclin referred to in the text are labelled. (B) Sequence alignment of three viral cyclins (accession codes: mhu91858, cgh2_hsvsa and ksu79416) with the D-type cyclins (accession codes: hscycd1, hscycd2 and hscycd3) and cyclin A3 (accession code: hscyclina). M-cyclin, V-cyclin and cyclin A3 were aligned based on structural superposition and analysis using SAP (Taylor and Orengo, 1989) . Helices in M-cyclin are indicated by boxes above the sequences and named following the convention used by Schulze-Gahmen et al. (1999) . The blue outline box highlights the cyclin box. The helices unique to M-cyclin are shown as blue boxes. Every tenth residue in the M-cyclin is marked with a dot. Conserved residues amongst mammalian cyclins are highlighted in green, whereas those speci®c to the viral and D-type cyclins are shaded black in reverse contrast or grey for R106 M (see text). M-cyclin (above sequences) and cyclin A (below sequences) residues contributing to the cdk interface are indicated by a number representing the amount of surface area of the side chain buried in the cyclin±cdk2 interface. 0 represents 1±10 A Ê 2 , up to 9, which indicates that >91 A Ê 2 of the side chain is buried in the interface. (C) Stereo view of the p27 Kip -binding site of cyclin A (purple) and the equivalent region of M-cyclin (gold) following superposition through their respective cdk2 subunits. p27 Kip is shown in pink. Some residues are omitted from the ®gure for clarity.
Crystal structure of a g-herpesvirus cyclin±cdk complex the PSTAIRE helix orientation differs slightly from that found in cyclin A±cdk2, it still suf®ces to preserve the interaction of E51 k2 with K33 k2 required for cdk2 catalytic activation. A further consequence of the position of M-cyclin bound to cdk2 is that almost half of the cdk2 T-loop is buried within the interface pincered between the N-terminus of M-cyclin and the PSTAIRE helix ( Figure 2C ). The presence of the N-terminus of M-cyclin within the interface with cdk2 was unexpected, but in preliminary experiments we have con®rmed that deletion mutants of M-cyclin lacking these sequences are unable to bind or activate cdk2 in vitro (P. Knowles and N.Q.McDonald, unpublished) . Equivalent N-terminal sequences were not observed in the V-cyclin structure, which was determined in the absence of a bound cdk subunit (Schulze-Gahmen et al., 1999) . This suggests that binding to the cdk subunit increases the degree of order in these sequences.
One of the remarkable features of viral cyclins is their capacity to evade inhibition by CKIs, suggesting that their expression would result in unrestrained cdk kinase activity in an infected cell. Previous predictions anticipated that sequence differences near the p27 Kip -binding site on viral cyclins would render it non-functional . From our M-cyclin±cdk2 structure, a more complex molecular explanation emerges for the inability of p27 Kip to inhibit active viral cyclin±cdk complexes. Rather than single or multiple sequence changes in the cyclin, it is a combination of sequence and conformational variation, particularly the main chain position of two structural H4±H5 loop and helix HC) , that leads to a markedly reduced af®nity for p27 Kip . In order to bind M-cyclin±cdk2, p27 Kip would have to overcome both unfavourable electrostatic and steric interactions. Several reports indicate that cyclin D±cdk6 complexes are able to engage p27 Kip but are not inhibited by p27 Kip in vivo (reviewed in Sherr and Roberts, 1999) . Whether the different mode of cdk engagement we describe for M-cyclin is used by cyclin D and how this perturbs p27 Kip ±cdk6 interaction and cdk6 activity are important questions raised by our study.
The T-loop conformation observed in M-cyclin±cdk2 differs considerably from that seen in other cdk2 structures (Jeffrey et al., 1995; Russo et al., 1996b; Brown et al., 1999) . For example, F152 k2 of the T-loop is buried within the complex interface and the viral cyclin D11 M chelates R150 k2 , tethering this portion of the T-loop. We anticipate that it is unlikely that residues 146±157 change conformation upon T160 k2 phosphorylation. However, residues 158±166 could reorganize about phosphorylated T160 k2 as in cyclin A-bound cdk2 such that V164 k2 adopts an a L conformation to form the P+1 pocket speci®c for the proline residue in cdk target sites (Russo et al., 1996b; Brown et al., 1999) . Since the viral cyclin±cdk complex is partially active, we infer that the C-terminal part of the T-loop must exhibit some¯exibility in solution.
Viral cyclins are known to alter the substrate speci®city of their cdk partners (Godden-Kent et al., 1997; Ellis et al., 1999; Mann et al., 1999) and are able to elicit a higher level of kinase activity than D-type cyclin±cdk6 complexes. Both of these properties may re¯ect the conformation of the phosphorylated T-loop bound to viral cyclin, and this will be clari®ed by structures of ternary complexes of substrate±viral cyclin±cdk. We cannot at present address whether the viral cyclin in¯uences substrate selection directly through the close proximity of its N-terminus to the T-loop or indirectly by altering the T-loop conformation to promote interaction with appropriate substrates. We note that sequences within the D-type cyclin N-terminus have previously been implicated in recruitment of cdk substrates such as pRb via the LXCXE motif, which is absent from the viral cyclins (Kato et al., 1993) .
Whether the M-cyclin±cdk2 complex reveals a novel virus-speci®c con®guration or one that is more widely shared by other cyclins must await further viral cyclin±cdk crystal structures. Given the highly divergent nature of the cyclin sequences, we note that there would need to be considerable selective pressure to retain a particular residue because it plays either a key structural role or a functional role such as contributing to cdk binding. The conservation of sequences D11 M , R106 M , W142 M and D151 M in the viral and D-type cyclins argues that cyclins with these residues bind their cdk partners in a similar manner to M-cyclin. Indeed, models of V-cyclin±cdk6 complex derived from M-cyclin H175R ±cdk2 appear to be consistent with this proposal (data not shown) but are Coordinates of a substrate peptide are also shown derived from the cyclin A±phosphorylated cdk2 complex (Brown et al., 1999) . Superposition of the substrate peptide onto M-cyclin±cdk2 shows a number of steric clashes in the region of the T-loop.
unable to explain why M-cyclin does not bind cdk4 or cdk6. Further experiments guided by the structure described here are required in order to establish that M-cyclin provides an appropriate model for other cyclin± cdk complexes.
Materials and methods

Plasmids and antibodies
The cyclin A construct, a gift from Dr Jonathan Pines, has the human cyclin A gene with a c-myc tag at its N-terminus transcribed from a cytomegalovirus (CMV) promoter. The following plasmids have been described previously: pcDNA3-cyclin D1 and pcDNA3-K cyclin . The gHV-68 cyclin clone, a gift from Dr William Burns (Wisconsin Medical School), was PCR subcloned into pRSETA (Invitrogen) using oligonucleotides that eliminated the EcoRI site at nucleotide 13 while conserving the amino acid sequence. In a manner identical to the cyclins described above, gHV-68 cyclin was N-terminally tagged by FLAG epitopes introduced by ligating a double-stranded oligonucleotide into the unique NcoI site in the pRSETA construct. A PCR mutation H175 to R gave a mutant M-cyclin, which was characterized in parallel with the wild-type viral cyclin.
For expression in mammalian cells, the tagged cyclin was subcloned into pcDNA3 via BamHI±EcoRI (Invitrogen). These constructs were a generous gift from C.Swanton. The co-immunoprecipitation experiments used the following antibodies: anti-cdk2 SC-163; anti-cdk4 SC-260; anticdk6 SC-177 (Santa Cruz Biochemicals); anti-FLAG (Sigma, M2); and anti-cyclin A (rabbit polyclonal, a gift from Jonathan Pines).
Cell culture, lysis and immunoprecipitation
The culture and transfection of U2-OS cells have been described previously (Mann and Jones, 1996) . Cells were split the day before being transiently transfected with 10 mg of mammalian expression constructs encoding cyclins. At 48 h post-transfection, cells were harvested by scraping cells into 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 10% glycerol, 1 mM dithiothreitol (DTT), 0.1% Tween-20, 10 mM b-glycerophosphate, 0.1 mM phenylmethylsulfonyl¯uoride (PMSF). Cell lysates were subject to immunoprecipitation for 2 h at 4°C with anti-FLAG antibodies conjugated to agarose (M2 Af®matrix; Kodak) or with anti-human cyclin A antibodies.
Immunoblotting and in vitro kinase assay
Immunoprecipitates from three parallel transient transfections were pooled and split into ®ve aliquots. One aliquot was used for immunoblotting. Immunoprecipitates were washed extensively, separated by SDS±PAGE and transferred to Protran (Schleicher and Schuell). Membranes were incubated with antibodies against cdk subunits (anticdk2 SC-163, anti-cdk4 SC-260 and anti-cdk6 SC-177; Santa Cruz Biochemicals) and visualized by ECL (Amersham Pharmacia Biotech). The other four aliquots were used in kinase assays. Immunoprecipitates were resuspended in 30 ml of 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 10 mM b-glycerophosphate, 50 mM ATP, 10 mCi of [g-32 P]ATP (6000 Ci/mmol) and 5 mg of puri®ed GST±Rb (C-terminus) as substrate with either 0, 0.1, 1 or 10 mg of puri®ed p27. Reactions were incubated for 30 min at 30°C and then loaded on a 10% SDS±polyacrylamide gel. Gels were dried and analysed by autoradiography and quantitated by phosphoimaging.
Preparation of the M-cyclin±cdk2 complex Human cdk2 was produced by a recombinant baculovirus (a gift from Professor D.Morgan, UCSF) used to infect Sf9 insect cells according to published protocols (Rosenblatt et al., 1993) . M-cyclin was produced as a GST-tagged fusion protein using the vector pGEX-KG vector (Guan and Dixon, 1991) in a DH5a bacterial host. Each 1 l culture, containing 200 mg of ampicilin, was grown at 37°C until an OD 600 nm of 0.7 was reached. The temperature was then lowered to 25°C until an OD 600 nm of 1.3 was attained, whereupon it was lowered further to 18°C before overnight induction with 0.025 mM isopropyl-b-D-thiogalactopyranoside (IPTG). The cells were harvested by centrifugation at 5000 g for 15 min at 4°C, before being resuspended in pre-cooled lysis buffer: 20 mM Tris pH 7.9, 100 ml NaCl, 1 mM EDTA, 0.5% Tergitol NP-40, 10 mM DTT, 10 mM leupeptin, 1 mM pepstatin A, 10 mM benzamidine and 1 mM PMSF. Sonication on ice was followed by centrifugation at 25 000 g for 30 min at 4°C, before the supernatant was batch-puri®ed on preequilibrated glutathione±Sepharose 4B resin (Pharmacia). Following three washes in lysis buffer and one in PBSA buffer (1.4 M NaCl, 30 mM KCl, 100 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 , 10 mM DTT), the resin was incubated overnight at 4°C with 6 U of thrombin (Boehringer Mannheim), leaving M-cyclin in the soluble fraction. The resin was removed using a PD10 column and any excess thrombin inactivated using inhibitors. The M-cyclin was then concentrated using an Amicon stirred cell, before being loaded onto a Superdex 75 FPLC column (Pharmacia), preequilibrated in running buffer: 50 mM Tris pH 7.9, 150 mM NaCl, 10 mM DTT. M-cyclin was isolated in an elution volume corresponding to a mol. wt of~29 000 Da, consistent with SDS±PAGE. The identity of M-cyclin was con®rmed by mass spectroscopy ®ngerprinting following limited trypsin digest.
Crystallization of the M-cyclin±cdk2 complex
The puri®ed human cdk2 and M-cyclin were mixed in an equimolar ratio before being concentrated in an Amicon stirred cell to 20 mg/ml. The complex was puri®ed further on a Superdex 75 FPLC column (Pharmacia), pre-equilibrated in the above running buffer. The M-cyclin±cdk2 complex eluted at a volume corresponding to a mol. wt of~63 000 Da. Crystals of the complex grew by vapour diffusion or micro-batch as thin single plates by mixing equal volumes of the complex at 6 mg/ml with the crystallization buffer; 0.1 M HEPES pH 7.5, 12% propan-2-ol, 5% polyethylene glycol 4000 (PEG 4K) and 10 mM DTT. Crystals regularly took only 4 h to grow at room temperature to dimensions of~100 3 100 3 4 mm, with the largest reaching 400 3 500 3 4 mm after 1 day. Crystals were harvested immediately to prevent further nucleation. The crystals tended to grow as multiclustered plates unsuitable for data collection. This was partially overcome by micro-or streak-seeding clear drops after 6 h.
Data collection and reduction
Owing to the thin nature of these crystals, a high intensity X-ray source was required. We collected a native data set on the micro-focus beam line ID13 at the European Synchrotron Research Facility (ESRF) at Grenoble, France. Data were recorded using a MAR Research CCD detector. Owing to the unique set-up of the station, the X-ray beam was collimated to 30 3 30 mm, allowing several images to be recorded from a single crystal, which was translated when the diffraction limit fell below 4 A Ê . The data were reduced using the programs DENZO and SCALEPACK (Otwinowski and Minor, 1997) . The statistics for the data are shown in Table I . The presence of two M-cyclin±cdk2 complexes per asymmetric unit was established from a self-rotation function and native Patterson synthesis. We note that the M-cyclin±cdk2 complex associates as a noncrystallographic dimer, which is quite different from that observed in three independent crystal forms of cyclin A±cdk2 (Brown et al., 1999) . The R175 M mutation places the guanidino group between F179 M and Y171 M , thereby making favourable interactions with the p electron clouds from their respective ring systems. It is still unclear how this improves the solubility of recombinant M-cyclin.
Structural determination and re®nement
Initial phases were obtained by molecular replacement after modi®cation of the complex structure of cdk2±cyclin A, PDB ID code 1FIN. The search model for cdk2 was left unaltered, but the cyclin A model was trimmed back to a polyalanine probe model but included side chains from conserved residues identi®ed from sequence alignment (15% of all side chains). The program AMoRE (CCP4, 1994) was used to search for the two molecules expected in the asymmetric unit, and two distinct solutions were obtained. The initial phases were improved further by applying 2-fold non-crystallographic symmetry (NCS) averaging using the programs MAMA and IMP (Jones et al., 1991) , and by solvent¯attening, histogram matching and phase extension with NCS averaging in the program DM (Cowtan, 1994) . Model building was performed using the program O (Jones et al., 1991) and initial re®nement carried out using X-PLOR incorporating R free validation of the progress of re®nement (Bru Ènger, 1996) . After four cycles of positional re®nement and one cycle of simulated annealing, re®nement was continued using CNS (Bru Ènger, 1998) . The ®nal R and R free values were 23.5 and 28.5%, respectively, with an r.m.s.d. of 0.0088 A Ê from ideal bond lengths and 1.41°for angles. Eighty-four per cent of residues were within the most favourable region of a Ramachandran plot.
